NCT06224686

Brief Summary

The goal of this clinical trial is to learn about on dysphagia in wallenberg syndrome. The main questions it aims to answer are:

  • the efficacy of motor imagery based on action observation treatment in the rehabilitation of patients with dysphagia in Wallenberg syndrome.
  • apply functional near infrared spectroscopy to explore the mechanism of action of this therapy. Participants received conventional dysphagia treatment and motor imagery based on action observation treatment once a day for 14 days. Researchers compared the control group to see the effect and mechanism of motor imagery based on action observation treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

January 6, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 25, 2024

Completed
Last Updated

January 25, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

January 6, 2024

Last Update Submit

January 17, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • standardized swallowing assessment

    The standardized swallowing assessment was used to assess the improvement of overall swallowing function, it has a maximum score of 46 and a minimum score of 18, with lower scores indicating better swallowing function.

    day 1 and day 14

  • cortical activation during volitional swallowing

    The functional near infrared spectroscopy system (Nirsmart, Danyang Huichuang Medical Equipment Co., Ltd., China) was used to detect changes in cerebralhemodynamics during the execution of volitional swallowing task.

    day 1 and day 14

  • cortical activation during swallowing motor imagery

    The functional near infrared spectroscopy system (Nirsmart, Danyang Huichuang Medical Equipment Co., Ltd., China) was used to detect changes in cerebralhemodynamics during the whole swallowing motor imagery.

    day 1

Secondary Outcomes (4)

  • Murray secretion scale

    day 1 and day 14

  • yale pharyngeal residue severity rating scale

    day 1 and day 14

  • Rosenbek penetration-aspiration scale

    day 1 and day 14

  • swallowing-quality of life

    day 1 and day 14

Study Arms (2)

The experimental group

EXPERIMENTAL

conventional dysphagia treatment and motor imagery based on action observation treatment

Other: conventional dysphagia treatmentOther: motor imagery based on action observation treatment

The control group

ACTIVE COMPARATOR

conventional dysphagia treatment

Other: conventional dysphagia treatment

Interventions

Conventional dysphagia treatment included oropharyngeal muscle movement training, orofacial alternating hot and cold stimulation, Masako swallowing training, Mendelsohn maneuver, therapeutic ingestion training, intermittent oral-esophageal tube feeding, and low-frequency electrical stimulation of swallowing neuromusculature, etc., 30 min each time, once a day for 14 consecutive days.

The control groupThe experimental group

First, the therapist explained the purpose and principle of the intervention method to the patient, keeping the surrounding environment quiet and comfortable to avoid the patient's mood fluctuations due to external interference. Then start the treatment, the video recorded in advance was given to the patient to watch, the playback device is a ipad. The content includes lip and tongue muscle relaxation exercises, healthy people eating, chewing, swallowing, drinking and other images. At the same time, the guidance was played, which was consistent with the content in the video. The video was played 3 times consecutively for 30 min each time, once a day for 14 days.

The experimental group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ranged from 18-80 years and right-handed;
  • first onset, vital signs stable and conscious;
  • the dysphagia confirmed by videofluoroscopic swallowing study;
  • no cognitive impairment, the mini-mental state examination score: \>17 for those with an illiterate education, \>20 for those with an elementary education, and \>24 for those with a secondary education and above;
  • good motor imagery ability with kinesthetic and visual imagery questionnaire-10 score ≥25;
  • cranial integrity without craniotomy and/or craniectomy;
  • patient and/or his/her relative agrees and signs written informed consent.

You may not qualify if:

  • combined ischemic foci at other sites;
  • presence of organic swallowing dysfunction or pre-existing dysphagia due to Parkinson's disease, dementia, and others;
  • severe cardiac, pulmonary, hepatic, and renal insufficiency and vital organ failure;
  • significant psychological disorders such as anxiety and depression;
  • infected or broken skin on the head;
  • poorly controlled epilepsy;
  • poor patient compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450000, China

Location

MeSH Terms

Conditions

Lateral Medullary SyndromeDeglutition Disorders

Condition Hierarchy (Ancestors)

Brain Stem InfarctionsBrain InfarctionBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesStrokeVascular DiseasesCardiovascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Xi Zeng

    The First Affiliated Hospital of Zhengzhou University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Master

Study Record Dates

First Submitted

January 6, 2024

First Posted

January 25, 2024

Study Start

May 30, 2023

Primary Completion

December 29, 2023

Study Completion

December 31, 2023

Last Updated

January 25, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

The datasets generated and analyzed during the current study are not publicly available due to the hospital's confidentiality regulations regarding trial data but are available from the corresponding author on reasonable request.

Locations